This document is a Pre-Solicitation Notice for the procurement of reagent kits and consumables from Qiagen LLC to be used for isolating DNA and RNA from the blood of stem cell transplant and hematological disorder patients at the NIH Clinical Center.
The NIH Clinical Center intends to award a firm fixed price contract to Qiagen LLC, the sole provider of the required reagents that are validated for use with the Center's existing instrumentation. The contract will cover the products listed in Attachment 1, including BCR-ABL fusion and JAK2 mutation assay kits, as well as various DNA/RNA extraction kits and consumables. The acquisition will use Simplified Acquisition Procedures under FAR Part 13, as the requirement is below the Simplified Acquisition Threshold. Interested parties capable of providing similar products may submit capability statements by the due date for the government's consideration, but the award to Qiagen is at the government's discretion.
